Present and future therapeutic options for locally advanced and metastatic renal cell carcinoma

Author： Sfoungaristos Stavros Giannitsas Konstantinos Perimenis Petros

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.12, Iss.4, 2011-03, pp. : 533-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vismodegib: In Locally Advanced or Metastatic Basal Cell Carcinoma

By Keating Gillian M.

Drugs, Vol. 72, Iss. 11, 2012-07 ,pp. : 1535-1541

Adis International

Access to resources Recommend Favorite

Phase II study of the efficacy and safety of oral GD0039 in patients with locally advanced or metastatic renal cell carcinoma

By Shaheen Philip Stadler Walter Elson Paul Knox Jennifer Winquist Eric Bukowski Ronald

Investigational New Drugs, Vol. 23, Iss. 6, 2005-12 ,pp. : 577-581

Springer Publishing Company

Access to resources Recommend Favorite

Targeting the Hedgehog Pathway for Locally Advanced and Metastatic Basal Cell Carcinoma

Current Pharmaceutical Design, Vol. 23, Iss. 4, 2017-03 ,pp. : 655-659

Bentham Science Publishers

Access to resources Recommend Favorite

VEGF Inhibitors in Metastatic Renal Cell Carcinoma: Current Therapies and Future Perspectives

Current Clinical Pharmacology, Vol. 6, Iss. 3, 2011-08 ,pp. : 164-168

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targeting Agents in Renal Cell Carcinoma: Present Strategies and Future Perspectives

Current Pharmaceutical Design, Vol. 14, Iss. 11, 2008-04 ,pp. : 1058-1077

Bentham Science Publishers

Access to resources Recommend Favorite